Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PACS +40.8%, CRNC +30.2%, ALLT +14.6%, KLIC +14.1%, NUTX +10.6%, NVDA +4.8%, VNET +2.5%, JOYY +1.8%, ZTO +1.1% (also increases share repurchase authroization to $2 bln), J +0.7%
Other news:
- FOSL +8.9% (CEO insider buy -- bought 200,000 shares at $1.75 - $1.82 worth about $360K)
- SMCI +5.7% (expands air-cooled AI solutions featuring AMD Instinct GPUs)
- PMI +5.5% (completes first in vivo implantations of next-generation Emperor Total Artificial Heart)
- EOSE +5.3% (prices upsized $525,000,000 convertible senior notes offering)
- AMD +4.5% (in sympathy with NVDA earnings)
- WRD +4.1% (secures Switzerland's first driverless robotaxi permit, expanding AV licensing to eight countries)
- REGN +4% (FDA approves EYLEA HD Injection 8 mg)
- AVGO +2.9% (in sympathy with NVDA earnings)
- MRVL +2.8% (in sympathy with NVDA earnings)
- MRNA +2.6% (Analyst Day)
- MU +2.3% (in sympathy with NVDA earnings)
- AXTA +2.3% (Artisan Partners Global Value criticizes Axalta--Akzo Nobel (AKZOY) merger)
- ONC +2.3% (showcases leadership in B-cell malignancies at ASH 2025)
- PRTA +2.1% (poster presentation on its TDP-43 CYTOPE program)
- ULS +2% (development of new lab in Germany)
- INTC +2% (in sympathy with NVDA earnings)
- ARMN +1.6% (long-term agreement with the Government of Colombia)
- AII +1.2% (prices offering of 3.0 mln shares of common stock at $20.00 per share)
- CDRE +1% (subsidiary awarded $50 mln contract with DoW)
- STEX +0.9% (stock offering by selling shareholders)
- MATW +0.9% (increases dividend)
- XRX +0.8% (names new CFO)